Apalutamide's FDA-approval is discussed, including discussion of its drug interaction potential and a review of the SPARTAN study.  Updates (18:15) from ASCO GU and DOAC use in cancer (23:50) also discussed.

Apalutamide's FDA-approval is discussed, including discussion of its drug interaction potential and a review of the SPARTAN study.  Updates

It's All Immunotherapy Nowadays

OncoPharm is a podcast dedicated to all things oncology pharmacy.  Most episodes cover updates and recent publications concerning the use of medications in caring for patients with cancer.  Periodically, episodes drop devoted to Landmark Clinical Trials in oncology and Fundamentals of Oncology Pharmacy.